Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Non-Current Debt (2020 - 2025)

Historic Non-Current Debt for Maravai Lifesciences Holdings (MRVI) over the last 6 years, with Q3 2025 value amounting to $287.4 million.

  • Maravai Lifesciences Holdings' Non-Current Debt fell 4433.65% to $287.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $287.4 million, marking a year-over-year decrease of 4433.65%. This contributed to the annual value of $290.5 million for FY2024, which is 4399.69% down from last year.
  • As of Q3 2025, Maravai Lifesciences Holdings' Non-Current Debt stood at $287.4 million, which was down 4433.65% from $288.4 million recorded in Q2 2025.
  • Maravai Lifesciences Holdings' 5-year Non-Current Debt high stood at $744.3 million for Q3 2021, and its period low was $287.4 million during Q3 2025.
  • Moreover, its 5-year median value for Non-Current Debt was $520.3 million (2023), whereas its average is $532.1 million.
  • Per our database at Business Quant, Maravai Lifesciences Holdings' Non-Current Debt soared by 3506.55% in 2022 and then crashed by 4433.65% in 2025.
  • Maravai Lifesciences Holdings' Non-Current Debt (Quarter) stood at $713.5 million in 2021, then dropped by 26.84% to $522.0 million in 2022, then decreased by 0.63% to $518.7 million in 2023, then crashed by 44.0% to $290.5 million in 2024, then dropped by 1.07% to $287.4 million in 2025.
  • Its last three reported values are $287.4 million in Q3 2025, $288.4 million for Q2 2025, and $289.5 million during Q1 2025.